Independent Data Monitoring Committee to Perform Interim Analysis of Phase 3 REGAL Study in January 2025 - - SLS009: Full Topline Phase 2 Data in Acute Myeloid Leukemia and FDA Regulatory Review Expec ...
Scotiabank lowered the firm’s price target on Kura Oncology (KURA) to $10 from $18 and keeps a Sector Perform rating on the shares. The firm ...
Scotiabank lowered the firm’s price target on Syndax (SNDX) to $16 from $18 and keeps a Sector Perform rating on the shares. The firm adjusted ...
Independent Data Monitoring Committee to Perform Interim Analysis of Phase 3 REGAL Study in January 2025 - - SLS009: Full Topline Phase 2 Data in Acute Myeloid Leukemia and FDA Regulatory Review Expec ...
A British mum has revealed how having puffy eyes ended up being a symptom of a rare form of cancer. Lizzie Spear, 56, had ...
CEO Bruce C. Cozadd sold 1,500 shares of the company’s stock in a transaction dated Thursday, January 2nd. The shares were ...
Little Aria Stevenson’s smiles are thanks to the kindness of strangers whose blood donations have helped her through ...
In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback